Cigna Invests $100 Million in AI-Powered Specialty Pharmacy Program to Improve Care for Complex Diseases

What's Happening

Health insurer Cigna, through its health services division Evernorth, has launched a new artificial intelligence (AI)-powered specialty pharmacy initiative called Pharmacy Forward, backed by a $100 million investment through 2028. The program is designed to streamline prescription processing, reduce administrative work for clinicians, and improve the experience for patients receiving specialty medications.

The initiative will initially be introduced through Accredo, Evernorth's specialty pharmacy, which manages medications for patients with serious and complex medical conditions. According to the company, AI will help integrate clinical information, summarize patient data, automate documentation, and accelerate prescription approvals, allowing pharmacists and clinicians to spend more time providing direct patient care.

The investment reflects a broader trend across healthcare, where insurers, providers, and pharmaceutical companies are increasingly adopting AI to improve operational efficiency while addressing growing demand for specialty care.

What Is Specialty Pharmacy?

Specialty pharmacies manage medications used to treat complex, chronic, or rare diseases that often require careful monitoring and ongoing clinical support.

Unlike traditional prescription drugs, specialty medications frequently:

• Require refrigeration or special handling.
• Are administered through injections or infusions.
• Need frequent laboratory monitoring.
• Have complex dosing schedules.
• Cost thousands of dollars per month.
• Require prior authorization from insurers.

Specialty pharmacies therefore provide much more than medication dispensing. They often coordinate:

• Insurance approvals
• Financial assistance programs
• Patient education
• Clinical monitoring
• Medication adherence
• Communication between physicians, nurses, and patients

Because of this complexity, specialty pharmacy has become one of the fastest-growing sectors within healthcare.

Why Specialty Pharmacy Is Growing

Advances in biotechnology have transformed the treatment of many serious diseases.

Today, specialty medications are commonly used for conditions such as:

• Cancer
• Multiple sclerosis
• Rheumatoid arthritis
• Psoriasis
• Crohn's disease
• Rare genetic disorders
• Hemophilia
• Pulmonary hypertension

Although fewer than 5% of Americans use specialty medications, these drugs account for more than half of total U.S. pharmacy spending because of their high cost and complexity.

As more advanced therapies enter the market, including gene therapies, cell therapies, and personalized medicines, the need for specialized pharmacy services continues to increase.

How AI Will Be Used

According to Cigna, Pharmacy Forward uses artificial intelligence to simplify many administrative tasks that currently require significant manual effort.

The system will help:

• Integrate Clinical Information: AI gathers patient information from multiple sources into a unified clinical view. This reduces the time clinicians spend searching through different medical records.
• Generate Clinical Summaries: Instead of manually reviewing lengthy patient histories, clinicians receive concise AI-generated summaries highlighting the most important information for treatment decisions.
• Reduce Documentation Burden: One of the program's primary goals is reducing clinician documentation time by up to 50%. Healthcare professionals often spend large portions of their day completing paperwork and electronic health record documentation. Automating part of this process may allow more time for direct patient interaction.
• Improve Prescription Processing: AI can help identify missing information, organize documentation, and accelerate insurance approval workflows. This may reduce delays before patients receive important medications.

Why Faster Prescription Processing Matters

Patients receiving specialty medications often face lengthy approval processes. Before treatment begins, prescriptions may require:

• Prior authorization
• Insurance verification
• Financial assistance review
• Clinical documentation
• Pharmacy coordination
• Physician approval

These steps can sometimes delay treatment by days or even weeks. For patients with serious illnesses such as cancer or autoimmune diseases, delays may increase anxiety and postpone important care. By automating portions of these workflows, AI may help patients receive treatment more quickly while reducing administrative work for healthcare providers.

Why Healthcare Is Investing Heavily in AI

Artificial intelligence has become one of healthcare's fastest-growing investment areas. Healthcare organizations are exploring AI applications across:

• Clinical documentation
• Medical imaging
• Drug discovery
• Population health management
• Revenue cycle management
• Patient scheduling
• Prior authorization
• Customer service

Unlike earlier AI initiatives that focused primarily on diagnostics, many current investments aim to reduce administrative burden. Healthcare professionals consistently report that documentation and paperwork contribute significantly to burnout. Organizations increasingly see AI as a tool that can improve efficiency while allowing clinicians to spend more time caring for patients.

Challenges AI Still Faces

Although AI offers significant potential, successful implementation requires careful oversight. Healthcare organizations must ensure AI systems:

• Protect patient privacy.
• Produce accurate clinical summaries.
• Avoid introducing bias.
• Integrate with existing electronic health record systems.
• Support clinicians rather than replace clinical judgment.

AI-generated recommendations still require review by qualified healthcare professionals. Regulators and healthcare organizations continue developing governance frameworks to ensure AI is used safely and responsibly.

Why This Investment Matters for Evernorth

Evernorth has become one of the largest health services organizations in the United States, operating across pharmacy benefit management, specialty pharmacy, care management, and behavioral health.

Specialty pharmacy is an increasingly important business because demand for high-cost specialty medicines continues to grow. By investing in AI now, Evernorth hopes to improve operational efficiency while positioning itself to manage the growing volume of complex therapies expected over the coming years.

The initiative also reflects increasing competition among pharmacy benefit managers and specialty pharmacy providers, many of whom are investing heavily in digital technologies to improve patient experience and reduce costs.

Industry Impact

• Health Insurers: AI is becoming an important tool for improving operational efficiency while managing rising specialty drug costs.
• Specialty Pharmacies: Automation may reduce administrative work and improve prescription turnaround times.
• Healthcare Providers: Clinicians could spend less time on documentation and more time providing direct patient care.
• Patients: Faster prescription processing and improved care coordination may reduce delays in accessing specialty medications.

Why This Matters

Cigna's investment illustrates how artificial intelligence is moving beyond experimental pilot projects and becoming part of everyday healthcare operations. Rather than replacing clinicians, AI is increasingly being used to reduce repetitive administrative tasks that consume valuable healthcare resources.

As specialty medications become more common and treatment pathways become increasingly complex, healthcare organizations will need technologies capable of managing large amounts of clinical information efficiently. Programs like Pharmacy Forward demonstrate how AI can support healthcare professionals while improving patient access to life-changing therapies. The success of these initiatives will ultimately depend on whether they deliver measurable improvements in efficiency, patient outcomes, and healthcare experience without compromising clinical quality or patient privacy.

Key Takeaways

• Cigna's Evernorth is investing $100 million through 2028 in an AI-powered specialty pharmacy program called Pharmacy Forward.
• The program will launch through Accredo, Evernorth's specialty pharmacy.
• AI will help automate documentation, integrate clinical information, generate patient summaries, and speed prescription processing.
• The company expects clinician documentation time to decrease by up to 50%.
• The initiative reflects growing investment in AI to improve specialty pharmacy operations and patient care.

What This Means for Healthcare Marketers

Cigna's investment demonstrates that artificial intelligence is rapidly becoming a core operational technology rather than simply a clinical innovation. While much of the industry's AI discussion has focused on diagnostics and drug discovery, this initiative highlights another important opportunity: reducing administrative complexity across the healthcare system.

For healthcare marketers, specialty pharmacy represents one of the fastest-growing areas of healthcare delivery. As more gene therapies, biologics, and personalized medicines enter the market, organizations will increasingly compete on the quality of patient support services rather than medication access alone. AI-enabled care coordination, faster prescription approvals, and improved clinician workflows are becoming meaningful differentiators for health plans, pharmacy benefit managers, and specialty pharmacies.

For healthcare intelligence teams, investments like Pharmacy Forward signal where future digital health spending is likely to concentrate. Monitoring AI adoption across pharmacy operations, prior authorization, care management, and patient engagement can help organizations identify emerging competitive advantages and evolving standards of care delivery.

More broadly, this initiative reflects a healthcare industry that is shifting AI toward practical, measurable improvements in everyday operations. If these technologies successfully reduce clinician workload while accelerating patient access to complex therapies, they could play an increasingly important role in improving both healthcare efficiency and patient experience.